The company’s executive management will participate in the Baader Investment Conference in Munich on September 21, followed by the Global Markets Forum in New York on October 7. These sessions offer a platform for one-on-one meetings with stakeholders interested in the company’s neurorehabilitation solutions, which target conditions including stroke and Parkinson's disease.
MindMaze Therapeutics Sets Global Investor and Industry Circuit
MindMaze Therapeutics Holding SA is preparing to showcase its precision neurotechnology platform across a series of high-profile events in the United States and Europe. The Swiss firm, listed on the SIX Swiss Exchange, intends to leverage these appearances to present real-world clinical evidence and engage with institutional investors.
Beyond investor relations, MindMaze is intensifying its presence at major medical gatherings. The schedule includes the AMRPA Educational Conference in Austin, the ACRM Annual Fall Conference in Washington, and the AAPM&R Annual Assembly in Orlando. The firm concludes its autumn circuit at HLTH USA in Las Vegas on November 17. At these venues, the company will focus on demonstrating how its AI-driven software and sensor technologies address the global shortage of specialized clinicians by scaling care from hospital settings to the home.
Comments (0)
No comments yet. Be the first!